Literature DB >> 4208283

Comparison of gentamicin, carbenicillin and gentamicin, and carbenicillin in Pseudomonas sepsis in monkeys.

S Saslaw, H N Carlisle, M Moheimani.   

Abstract

Intravenous inoculation of 6.0 x 10(10)Pseudomonas aeruginosa organisms into rhesus monkeys 4 days after intratracheal inoculation of 2.5 mg of vincristine sulfate resulted in fatal sepsis in all of three untreated control monkeys. After intramuscular administration of either 2.5 mg of gentamicin or 50 mg of carbenicillin per kg per day, three of four monkeys in each group survived. When both antibiotics were given at the same dose but in separate sites, six of eight monkeys survived. Antibacterial activity of serum from infected monkeys or normal monkeys was not appreciably different when the two antibiotics were combined. Under the conditions of this study, there was no apparent difference in response of monkeys treated either with gentamicin or carbenicillin alone or with the combination of the two antibiotics.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4208283      PMCID: PMC444400          DOI: 10.1128/AAC.3.2.274

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Carbenicillin treatment of Pseudomonas pulmonary infection. Use in children with cystic fibrosis.

Authors:  J P Phair; J S Tan; C Watanakunakorn; L Schwab; L W Sanders
Journal:  Am J Dis Child       Date:  1970-07

2.  Clinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea.

Authors:  W Brumfitt; A Percival; D A Leigh
Journal:  Lancet       Date:  1967-06-17       Impact factor: 79.321

3.  Use of gentamicin in combinations with other antibiotics.

Authors:  C B Smith; P E Dans; J N Wilfert; M Finland
Journal:  J Infect Dis       Date:  1969 Apr-May       Impact factor: 5.226

4.  Carbenicillin: clinical and laboratory studies.

Authors:  R W Lyons; G F Thornton; V T Andriole
Journal:  J Infect Dis       Date:  1970-09       Impact factor: 5.226

5.  Pseudomonas infection treated with carbenicillin and gentamicin.

Authors:  R G Cooper; J C Rice; J L Penfold
Journal:  Med J Aust       Date:  1969-03-08       Impact factor: 7.738

6.  Combined action of carbenicillin and gentamicin on Pseudomonas aeruginosa in vitro.

Authors:  M Sonne; E Jawetz
Journal:  Appl Microbiol       Date:  1969-06

7.  Laboratory and clinical studies of carbenicillin against gram-negative bacilli.

Authors:  H C Standiford; A C Kind; W M Kirby
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

8.  In-vitro activity of carbenicillin and results of treatment of infections due to Pseudomonas with carbenicillin singly and in combination with gentamicin.

Authors:  C B Smith; J N Wilfert; P E Dans; T A Kurrus; M Finland
Journal:  J Infect Dis       Date:  1970-09       Impact factor: 5.226

9.  In vitro susceptibility of Pseudomonas aeruginosa to carbenicillin and the combination of carbenicillin and gentamicin.

Authors:  J P Phair; C Watanakunakorn; T Bannister
Journal:  Appl Microbiol       Date:  1969-09

10.  In vitro effects of carbenicillin combined with gentamicin or polymyxin B against Pseudomonas aeruginosa.

Authors:  T C Eickhoff
Journal:  Appl Microbiol       Date:  1969-09
View more
  1 in total

1.  Synergistic activity of carbenicillin and gentamicin in experimental Pseudomonas bacteremia in neutropenic rats.

Authors:  R E Scott; H G Robson
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.